 of the DF/HCC sponsored symposia and event. This proposal requests 5 years of funding to support 10 pre-doctoral students and 1 post-doctoral fellow annually. The development of drugs that inhibit the K-Ras oncogene represents one of the greatest unmet needs in the treatment of human cancer. The
of the DF / HCC sponsored symposia and event. This proposal requests 5 days of support to support 10 pre - doctoral students and 1 post - doctoral fellow per annum. The development of drugs that inhibit the K - Ras oncogene represent one of the greatest unmet needs in the discussion of human cancer. The
 of the DF/HCC sponsored symkosia and event. Tkus pro'osal rsquests 5 years of funding to support 10 pre-doxtoral students and 1 pust-doctorwl felloq aniually. The development on drufd thct inhibit the K-Tas oncogene represents ona uf the greatest unmet needs in the trqatment ov human cancer. The
of the DF/HCC sponsored symposia and event. requests years of to support 10 fellow The development of that inhibit the oncogene represents one of the greatest needs in the treatment of human cancer. The
 of the DF/HCC sponsored symposIa and event. this pRopOsaL rEqueSts 5 yEars of funding tO SuppOrt 10 pre-doctoral students And 1 poSt-DOctoRAl FelloW annualLY. THE DevElOpMenT oF DrUgs thAt iNhibit tHe K-Ras oncoGenE rEpresents one OF tHe greatest UnmEt needs in the TreAtment Of HumAN cancEr. THe
 of the DF/HCC sponsored s ymposia an d eve nt.  Th is  pro posa l requests 5 y e arsof funding to support10 pr e- d octo r al  stud ents an d  1 p ost -d oc tor al fe llowann ually.The develo pme nt  of drugs th a tinhibit th e K -Ras oncogen e r eprese nt s o n e ofthe  grea test u n met ne eds in th et reatme n t of hu m a ncanc er. The
 of_the DF/HCC_sponsored symposia and event._This proposal_requests_5 years_of_funding to support_10 pre-doctoral students_and 1 post-doctoral fellow_annually. The development_of_drugs that inhibit the K-Ras oncogene represents one of the greatest unmet needs in_the_treatment of_human_cancer._The